MedCity News

AUGUST 20, 2023

Pharmaceutical manufacturers say high U.S. prices support research and development and point out that Americans tend to get new treatments first. But recent research has shown that the price of a drug is related neither to the amount of research and development required to bring it to market nor its therapeutic value.

Pharmaceutical manufacturing 95

Pharmaceutical manufacturing Manufacturing Pharmaceutical Marketing 95

European Pharmaceutical Review

SEPTEMBER 14, 2023

Alongside this move, AstraZeneca’s investment in major energy efficiencies in its operations, brings the total of its financial commitment to net zero, to £100 million. Once operational in early 2025, the partnership will reduce emissions by an estimated 20,000 tonnes CO 2 equivalent (CO 2 e).

Manufacturing 111

Manufacturing Medicine Pharmaceutical manufacturing Pharma 111

European Pharmaceutical Review

SEPTEMBER 26, 2022

Martin Shanahan, CEO of IDA Ireland declared: “It is a very significant day for a plant that already has a long and proud record of pharmaceutical manufacturing and innovation. Earlier this year, AbbVie was named Best Workplace for Women and ‘Biopharma Company of the Year’ at the latest Irish Pharma Industry Awards.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

MedCity News

AUGUST 16, 2022

This “operational technology” (OT) is critical for pharmaceutical manufacturing and R&D organizations. Today’s factory floors include production equipment that’s linked directly into those IT systems that are so often the victims of a cyberattack.

Pharmaceutical manufacturing 92

Pharmaceutical manufacturing Manufacturing Pharmaceutical Biopharma 92

European Pharmaceutical Review

SEPTEMBER 22, 2022

Moreover, pharmaceutical manufacturing poses a huge detriment to the state of the planet’s ecosystem. Active pharmaceutical ingredients (APIs) are particularly impact intensive, soaking up a large quantity of resources in terms of heat, energy and water when being produced.

Transportation 105

Transportation Pharmaceutical manufacturing Biopharma Pharmaceutical 105

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. ” Image from the Association of the British Pharmaceutical Industry (ABPI).

Manufacturing 109

Manufacturing Medicine Government Pharmaceutical manufacturing 109

pharmaphorum

NOVEMBER 1, 2022

The new funding will establish a new pharmaceutical manufacturing scholarship programme – backed with $42.5 The university spent around $19 million on biopharma research in 2021. ” As a result, he continued, “the most advanced drugs are too costly to help as many people as they could.

Manufacturing 52

Manufacturing Biopharma Medicine Pharmaceutical manufacturing 52

pharmaphorum

AUGUST 4, 2022

In particular, for the pharmaceutical industry, these talent shortages bring about a host of difficult challenges. This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. Training and development.

Recruitment 94

Recruitment Pharma Training Pharmaceutical manufacturing 94

pharmaphorum

DECEMBER 28, 2022

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. In the last 15 years, there has been a noticeable shift towards many prominent players effectively outsourcing innovation to start-ups due to the increasing cost of R&D.

Pharma 112

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 112

PM360

SEPTEMBER 30, 2024

In late 2023, Deloitte found that over half of 105 surveyed global biopharma leaders were committed to reducing environmental impact and advancing sustainability by minimizing water use, sourcing sustainable materials, and overhauling supply chains.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Defossilization of pharmaceutical manufacturing.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1]

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

Clarivate

AUGUST 20, 2024

In announcing the results of price negotiations between the Centers for Medicare & Medicaid Services (CMS) and pharmaceutical manufacturers, the federal government has demonstrated that it can replicate private payers’ ability to reduce the net price of treatment while focusing on the clinical benefit of a treatment versus therapeutic alternatives (..)

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52